StonvexLoading…
StonvexStonvexStonvexCore line items from NL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $158.28M | $145.94M | $161.29M | $166.56M |
Operating Income | $10.68M | $37.88M | $14.13M | $13.73M |
Net Income | $-37.83M | $67.23M | $-2.31M | $33.84M |
EPS (Diluted) | $-0.77 | $1.38 | $-0.05 | $0.69 |
Total Assets | $464.22M | $578.26M | $576.66M | $609.87M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $110.61M | $163.15M | $111.52M | $68.87M |
Free Cash Flow OCF − CapEx | $-40.15M | $24.14M | $35.87M | $23.24M |
Shares Outstanding | 48.86M | 48.85M | 48.83M | 48.82M |